ORIGINAL RESEARCH
Published on 07 Nov 2025
Engineering HER2-targeted biparatopic antibodies to promote receptor internalization and restore antitumor efficacy
doi 10.3389/fimmu.2025.1711433
- 1,098 views
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- AntibodyPlus Therapeutics in Oncology: Innovative Mechanisms, Therapeutic Strategies, and Clinical Advances
AntibodyPlus Therapeutics in Oncology: Innovative Mechanisms, Therapeutic Strategies, and Clinical Advances
122
Total downloads
4,895
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Published on 05 Nov 2025
Harnessing IgM for solid tumor therapy: biology, engineering advances, and translational challenges
doi 10.3389/fimmu.2025.1712344
- 1,592 views
ORIGINAL RESEARCH
Published on 27 Oct 2025
Biparatopic HER2-targeted nanobody binder synergizes with trastuzumab in resistant tumor cells
doi 10.3389/fimmu.2025.1711448
- 1,085 views
Published in
Frontiers in Oncology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Immunology
- 5.9 impact factor
- 10.8 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: